Product NewsRyzodeg® Offers Simpler Solution with Once-Daily Dosing and Reduced Risk of Nocturnal Hypoglycaemia vs Insulin
Product NewsOzempic Reduces Risk of Major Cardiovascular Events Across Type 2 Diabetes Populations at High CV Risk
Product NewsRyzodeg Shown to Significantly Reduce the Risk of Low Blood Sugar in People with Type 2 Diabetes Who Fast During Ramadan
Industry NewsParticipants Report Xultophy a Better Option than Basal-Bolus Insulin Therapy in DUAL VII Clinical Trial on Managing Type 2 Diabetes
